Page 1218 - Basic _ Clinical Pharmacology ( PDFDrive )
P. 1218

1204     Index


                 Degree of spareness, 22f, 23          isotretinoin, 1077–1078            fluorouracil, 1083
                 Dehydroemetine, 929t, 931             retinoic acid derivatives, 1077    ingenol mebutate, 1083–1084
                 Dehydroepiandrosterone (DHEA), 740  antibacterial agents, topical        NSAIDs, 1084
                 Dehydroepiandrosterone sulfate (DHEAS),   bacitracin and gramicidin, 1070  podophyllum resin and podofilox,
                        740                            fundamentals of, 1070                  1083
                 Delavirdine, 871t, 877                mupirocin, 1070                    propylene glycol, 1082
                 Delayed afterdepolarizations (DADs), 218,   neomycin and gentamicin, 1071  salicylic acid, 1082
                        233, 233f                      polymyxin B sulfate, 1070–1071     sinecatechins, 1083
                 Delayed effects, 49                   retapamulin, 1070                  urea, 1082–1083
                 Delayed-type hypersensitivity (DTH), 983,   antibacterial agents, topical acne  melanoma agents, 1085
                        984f                           clindamycin, 1071                other agents, 1086t
                 Delirium tremens, 400                 dapsone, 1072                    percutaneous absorption in, 1068,
                   management of, 403                  erythromycin, 1071                     1069df
                   mortality rate for, 585             metronidazole, 1071              pharmacology response in, 1068
                   sedative-hypnotics for, 391         sodium sulfacetamide, 1071–1072  pigmentation agents, 1076–1077
                 Delta opioid receptors, 553, 554t   antifungal agents, oral              hydroquinone, monobenzone, and
                 Demeclocycline, 817                   azole derivatives, 1073                mequinol, 1076
                 Dendrites, 368                        griseofulvin, 1074                 trioxsalen and methoxsalen, 1076
                 Denervation supersensitivity, 103     terbinafine, 1074                psoriasis drugs
                 Denileukin diftitox, 998            antifungal agents, topical           acitretin, 1078
                 Denosumab, 995                        allylamines, 1073                  biologic agents, 1079
                   on bone homeostasis, 781            azole derivatives, 1072              fumaric acid esters, 1079
                   osteoporosis treated with, 775, 780b,   butenafine, 1073                 TNF inhibitors, 1079
                        787, 790t                      ciclopirox olamine, 1072             ustekinumab, 1079
                 Deoxycorticosterone (DOC), 714–715    nystatin and amphotericin B, 1073  calcipotriene and calcitriol,
                 Deoxycytidine analogs                 tolnaftate, 1073                       1078–1079
                   cytarabine, 958t, 960             anti-inflammatory agents, 1079–1082  tazarotene, 1078
                   gemcitabine, 958t, 960              corticosteroids, topical, 1079–1081,   sunscreens, 1076–1077
                 Dependence, physical, 389, 576–578        1080t, 1081t                 trichogenic and antitrichogenic agents
                   alcohol (ethanol), 396, 400         tar compounds, 1082                bimatoprost, 1085
                   benzodiazepine, 584               antineoplastic agents                eflornithine, 1085
                   clinical pharmacology of, 587–588   alitretinoin, 1085                 finasteride, 1085
                   definition of, 559, 575             bexarotene, 1085                   minoxidil, 1084–1085
                   opioid, 559, 564–565, 566           romidepsin, 1085               Dermatologic vehicles, 1068–1070
                   sedative-hypnotics, 389–390         vismodegib, 1085               Desensitization, 32, 33f
                   on sedative-hypnotics, 391          vorinostat, 1085                 of adrenoreceptors, 141
                   tolerance in, 576–578             antipruritic agents                by G protein-coupled receptor kinases,
                   withdrawal, 576–578                 doxepin, 1084                          141
                 Depression                            pramoxine, 1084                  heterologous, 141
                   acute bipolar, antipsychotics for, 519  antiseborrhea agents, 1084, 1084t  homologous, 141
                   from female hormonal contraceptives, 735  antiviral agents, topical, 1074  membrane, by muscle relaxants, 479f,
                   major depressive disorder, 526, 532–536.   dermatologic vehicles, 1068–1070  480
                        See also Major depressive disorder   drug reactions, 1068, 1070t  Desflurane, 441–449. See also Anesthetics,
                        (MDD)                        ectoparasiticides                        inhaled
                   pathophysiology of, 533–536         benzyl alcohol, 1076             properties of, 443t
                    integration of hypotheses on, 536  crotamiton, 1075                 structure of, 443f
                    monoamine hypothesis in, 533,      ivermectin, 1075               Design, rational drug, 4
                        534–536, 535f                  lindane, 1075                  Desipramine, 537, 546t
                    neuroendocrine factors in, 536     malathion, 1076                Desloratadine, 281, 283t, 296t. See also
                    neurotrophic hypothesis in, 533f,   permethrin, 1075                      H 1 -receptor antagonists
                        533–534                        spinosad, 1075                 Desmethyldiazepam, 382f
                   recurrent, lithium for, 526         sulfur, 1075                   Desmopressin
                   unipolar, antipsychotics for, 519  immunomodulators                  description of, 681–682, 684t
                 Dermatologic pharmacology, 1068–1086  imiquimod, 1074                  diuresis using, 268
                   acne preparations                   tacrolimus and picrolimus,       structure of, 681f
                    azelaic acid, 1078                     1074–1075                  Desmopressin acetate, 622, 622t
                    benzoyl peroxide, 1078           keratolytic and destructive agents  Desogestrel, 728, 728t, 729f. See also
                    brimonidine, 1078                  aminolevulinic acid, 1084              Progestins
   1213   1214   1215   1216   1217   1218   1219   1220   1221   1222   1223